← All startups
IDRx logo

IDRx

Intelligently designed precision therapies, including a novel KIT inhibitor being developed for GIST

9 people
Latest roundFunding roundFeb 10, 2022
Listed Feb 2022Bio + Health

Team9

NameLocationLinksContact
Alexis Borisy
Co-Founder
Boston, Massachusetts, United States
—
Jessica Anderson Christo
Chief Development Operations Officer
United States
—
Debbie Johnson
Vice President Clinical Operations
Boston, Massachusetts, United States
—
James Shao
Vice President
Boston, Massachusetts, United States
—
Caitlin Albrecht
Director
—
—
Gozde Colak
Senior Medical Director
—
—
Latasha Nisbett
Associate Director
—
—
Elizabeth Campbell
Sr Clinical Trial Manager
—
—
Zina Rakita
Senior Accounting Manager
—
—
Join Discord